Literature DB >> 16202598

134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands.

E Bertini1, A Burghes, K Bushby, B Estournet-Mathiaud, R S Finkel, R A C Hughes, S T Iannaccone, J Melki, E Mercuri, F Muntoni, T Voit, B Reitter, K J Swoboda, D Tiziano, E Tizzano, H Topaloglu, B Wirth, K Zerres.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16202598     DOI： 10.1016/j.nmd.2005.07.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  19 in total

1.  Spinal muscular atrophy: advances in research and consensus on care of patients.

Authors:  Ching H Wang; Mitchell R Lunn
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

2.  Drug treatment for spinal muscular atrophy types II and III.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

3.  Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type I.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Charles Scott; Wendy King; Jill T Hartman; Laura E Case; Donata Viazzo-Trussell; Janine Wood; Carolyn A Roman; Eva Hecker; Marianne Meffert; Maude Léveillé; Krista Kienitz; Kathryn J Swoboda
Journal:  Pediatr Phys Ther       Date:  2013       Impact factor: 3.049

4.  Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy.

Authors:  Kristin J Krosschell; Charles B Scott; Jo Anne Maczulski; Aga J Lewelt; Sandra P Reyna; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2011-06-22       Impact factor: 3.217

5.  Spectrum of neuropathophysiology in spinal muscular atrophy type I.

Authors:  Brian N Harding; Shingo Kariya; Umrao R Monani; Wendy K Chung; Maryjane Benton; Sabrina W Yum; Gihan Tennekoon; Richard S Finkel
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

Review 6.  Perspectives on clinical trials in spinal muscular atrophy.

Authors:  Kathryn J Swoboda; John T Kissel; Thomas O Crawford; Mark B Bromberg; Gyula Acsadi; Guy D'Anjou; Kristin J Krosschell; Sandra P Reyna; Mary K Schroth; Charles B Scott; Louise R Simard
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

Review 7.  Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.

Authors:  Ryan S Anderton; Bruno P Meloni; Frank L Mastaglia; Sherif Boulos
Journal:  Mol Neurobiol       Date:  2013-01-13       Impact factor: 5.590

8.  Observational study of spinal muscular atrophy type I and implications for clinical trials.

Authors:  Richard S Finkel; Michael P McDermott; Petra Kaufmann; Basil T Darras; Wendy K Chung; Douglas M Sproule; Peter B Kang; A Reghan Foley; Michelle L Yang; William B Martens; Maryam Oskoui; Allan M Glanzman; Jean Flickinger; Jacqueline Montes; Sally Dunaway; Jessica O'Hagen; Janet Quigley; Susan Riley; Maryjane Benton; Patricia A Ryan; Megan Montgomery; Jonathan Marra; Clifton Gooch; Darryl C De Vivo
Journal:  Neurology       Date:  2014-07-30       Impact factor: 9.910

9.  Segmental Spinal Muscular Atrophy Localised to the Lower Limbs: First case from Oman.

Authors:  Roshan Koul; Amna Al-Futaisi; Khalid Al-Thihli; Zandre Bruwer; Patrick Scott
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

Review 10.  Therapeutics development for spinal muscular atrophy.

Authors:  Charlotte J Sumner
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.